Brainsway Ltd. American Depositary Shares (BWAY) — Analysis Summary
Brainsway Ltd. American Depositary Shares (BWAY) has a market cap of $578.72M with year-over-year revenue growth of +29.0%. Net margin stands at 7.1%. The stock trades at a P/E ratio of 198.1.
Key Takeaways
- Revenue changed +29.0% year-over-year
- Net margin of 7.1%
- P/E ratio of 198.1
Compared with its sector, BWAY posted revenue growth of +29.0% and trades at a P/E of 198.1.
Brainsway Ltd. American Depositary Shares (BWAY)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at 0.9x — earnings do not cover interest payments
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Employees
129
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.